Siemens Healthineers stock
Price history
+4.04% over the period1 year: from €41.29 (November 20, 2025) to €42.96 (November 20, 2026), +4.04%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | €42.96 |
| October 30, 2026 | €42.89 |
| September 30, 2026 | €37.97 |
| August 31, 2026 | €39.13 |
| July 31, 2026 | €36.86 |
| June 30, 2026 | €34.20 |
| May 29, 2026 | €34.92 |
| April 30, 2026 | €34.88 |
| March 31, 2026 | €36.30 |
| February 27, 2026 | €42.14 |
| January 30, 2026 | €42.17 |
| December 30, 2025 | €44.92 |
| November 28, 2025 | €42.84 |
| November 20, 2025 | €41.29 |
At a glance
The company
Develops, manufactures and sells diagnostic and therapeutic medical imaging, diagnostics, cancer care and minimally invasive procedure systems and services
Latest results
Quarter to September 30, 2026 · EPS €0.69 (estimate €0.67)
Next event
TickerLandia's take on Siemens Healthineers
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 22 vs a median of 27 over its last 9 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 22 vs 28 (−21%) in a group of 10.
- Strong point: Market momentum (76/100 in its group). Weak point: Profitability (27/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−9.10% from the 52-week high
Analysts · 20 analysts
Average target€46.75+8.81% vs. price
Buy 12 · Hold 8 · Sell 0 · Buy
TickerLandia Fingerprint: Siemens Healthineers
Compared with similar companies: strong momentum, low price, and low profitability.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow26
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 22.3 22 EV/EBITDA 13.7 28 Price/book 2.40 24 Forward P/E 16.3 32 Price/sales 2.03 21 Profitabilitylow27
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 38.6% 8 ROA 4.4% 21 Operating margin 13.5% 21 Net margin 9.4% 34 ROE 11.8% 50 Earnings stabilityhigh65
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.6% 73 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 56 Growthlow36
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +2.91% 21 Revenue growth (year over year) +7.30% 47 Earnings growth (year over year) −0.80% 40 Financial strengthlow33
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.38 78 Debt/equitycounts in reverse: lower means more financial strength 0.74 18 Current ratio 1.18 11 Interest coverage 7.83 25 Dividendaverage55
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 51.8% 52 Consecutive dividend years at least 8 years 44 Dividend yield 2.3% 69 Market momentumstrong76
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +13.05% 83 Relative strength (6 months) +25.17% 91 1-year return +4.04% 43 Distance from 200-day average +13.16% 86 Riskaverage43
How much the price swings.
Metric Value Position in group Beta (1 year) 0.69 46 Volatility (60 days) 20.0% 19 Maximum drawdown (12 months) 29.0% 66
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Siemens Healthineers is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2026), Siemens Healthineers's P/E today is 21.8, below the median of its last 9 fiscal years (27.4; between 19.3 and 35.8 from 2018 to 2026). Siemens Healthineers's P/E (trailing 12 months): 22.3, −21% against the median of a group of 10 similar companies (28.3).
Compared with 10 similar companies
| Metric | Siemens Healthineers | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 22.3 | Low | |
| Forward P/E | 16.3 | Middle | |
| Operating margin | 13.5% | Middle | |
| ROE | 11.8% | Middle | |
| Debt/equity | 0.74 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Siemens Healthineers. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€6.78B
Latest quarter · Q3 2026
Net income
€589M
Latest quarter · Q3 2026
Quarterly net margin
8.7%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- €48.08B
- P/E
- 22.3
- EPS
- €1.93
- Volume
- 1.14M
- Daily trading
- €46.84M
- Dividend yield
- 2.33%
- Last ex-dividend on February 6, 2026
How Siemens Healthineers is changing
All resultsRevenue grew 5.6% a year on average over the last 5 years
Operating margin rose from 9.8% to 13.5%
Profits turn into cash: free cash flow equal to 116% of net income
Returns
Siemens Healthineers returns with dividends
€1,000 invested in Siemens Healthineers 5 years ago, on November 22, 2021, would be worth €717 today with dividends reinvested: −28.29% in total, −6.44% per year. On price alone it would be €653 (−34.67%).
| Period | Siemens Healthineers | DAX | €1,000 becomes |
|---|---|---|---|
| 1 month | +3.67% | −1.98% | €1,037 |
| 6 months | +25.50% | +0.26% | €1,255 |
| Year to date | −4.36% | +1.28% | €956 |
| 1 year | +6.56% | +6.55% | €1,066 |
| 3 years | −8.85% | +55.98% | €912 |
| 5 years | −28.29% | +53.90% | €717 |
Over the last 6 months it has done better than 58% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment
The chart in detail
Siemens Healthineers: technical analysis
Siemens Healthineers is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 36.1% below its all-time closing high (€67.20, December 9, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 52
- Between 30 and 70
- vs 200-session average
- +13.16%
Support and resistance
Price areas where Siemens Healthineers has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price€42.96
- Support€42.77−0.44%3 touches, last on November 11, 2026
- Support€39.54−7.96%7 touches, last on September 29, 2026
- Support€36.90−14.11%3 touches, last on October 5, 2026
Volatility and risk
Over the last year it has moved less than the DAX.
- Beta (1 year) vs DAX
- 0.69
- Volatility (60 sessions, annualised)
- 20.0%
- Largest fall in the last year
- −29.01%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Siemens Healthineers: seasonality
Average monthly price change over 9 years
Over the last 9 years, the strongest month for Siemens Healthineers has been November: +6.85% on average, positive in 7 years out of 8. The weakest has been September: −1.65% on average, positive in 4 years out of 9.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.66% | −1.10% | 3 of 8 |
| February | −0.57% | +0.28% | 4 of 8 |
| March | −1.34% | −0.43% | 4 of 8 |
| April | −0.63% | −3.34% | 4 of 9 |
| May | +1.45% | +0.11% | 5 of 9 |
| June | −0.09% | +0.79% | 5 of 9 |
| July | +2.89% | +3.06% | 8 of 9 |
| August | −1.47% | +0.02% | 5 of 9 |
| September | −1.65% | −2.73% | 4 of 9 |
| October | +1.10% | +2.28% | 5 of 9 |
| November | +6.85% | +7.87% | 7 of 8 |
| December | +0.04% | −0.44% | 3 of 8 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Siemens Healthineers and its competitors
Imaging, the first of the four reporting segments, covers MRI and CT scanners, X-ray, molecular imaging and ultrasound systems, together with software for reading diagnostic images. The other segments address laboratory and point-of-care testing, cancer treatment technologies and clinical services from Varian, and image-guided minimally invasive procedures in cardiology, neurology and oncology. Customers are healthcare providers in Germany, the United States, the rest of Europe, the Middle East, Africa, the Americas, Asia Pacific, Japan and China.
- Headquarters
- Forchheim, Germany
- Employees
- 74,600
- Founded
- 1896
- Chief executive
- Bernhard Montag
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Siemens HealthineersSHL | $52.84B | 13.5% | 22.3 | +25.50% |
| Koninklijke PhilipsPHIA | $28.35B | 8.8% | 26.7 | +15.14% |
| Sonova HoldingSOON | $20.67B | 20.6% | 28.9 | +43.74% |
| Smith & NephewSN. | $12.57B | 14.2% | 20.8 | 0.00% |
| DemantDEMANT | $10.7B | 17.2% | 30.1 | +44.56% |
| GetingeGETI.B | $7.39B | 14.3% | 26.6 | +40.54% |
Same industry or related industries, similar size. Compare Siemens Healthineers with its competitors · Full profile
